Intestinal parasitic infections are among the most common human infections worldwide and are considered as critical health indicators of a community, especially in developing countries [1]. According to the World Health Organization (WHO) report, more than two billion people in the world are infected with intestinal parasitic infections [2-3]. More than 1.5 billion (24%) of the world's population are estimated to be infected with parasitic infections such as Ascaris lumbricoides, hookworms and Trichuris trichiura [4]. These infections are widespread mainly in tropical and subtropical regions. The highest incidences are reported from developing countries, more in sub-Saharan Africa, North and South America, China, and East Asia, where people are struggling with health problems, insufficient water supply, rapid population growth and other economic and social problems [4-6]. The most prominent pathogenic protozoa of human intestine are Giardia intestinalis, Entamoeba histolytica/Entamoeba dispar, Dientamoeba fragilis and Blastocystis sp. [3, 6]. Giardia intestinalis is one of the most common etiological agents of parasitic diarrhea in humans and animals. This parasite has a global distribution, and it is estimated that 280 million people are affected by this parasite worldwide [7]. The global prevalence of this protozoon in human has been estimated to be about 8 to 30% in developing countries and 1 to 8% in developed countries [8]. In Iran, like other developing countries, parasitic diseases in communities are considered